Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Emory University
Alliance for Clinical Trials in Oncology
Massachusetts General Hospital
Children's Oncology Group
M.D. Anderson Cancer Center
Shanghai Chest Hospital
NRG Oncology
Erasmus Medical Center
AIDS Malignancy Consortium
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Tongji Hospital
Erasmus Medical Center
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Registre des Tumeurs Digestives du Finistère
AIDS Malignancy Consortium
Shanghai Chest Hospital
Indiana University
National Cancer Institute (NCI)
The Rogosin Institute
European Organisation for Research and Treatment of Cancer - EORTC
University of Southern Denmark
Ludwig-Maximilians - University of Munich
University of Southern Denmark
UNICANCER
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC